In hepatocellular carcinoma (HCC), Huang et al. showed that SMOC2 overexpression attenuated the tumorigenicity and was associated with better prognosis12 whereas Su et al. reported that overexpression of SMOC2 promoted HCC cell proliferation and cell cycle progression13. Here, SMOC2 is linked to hepatocellular carcinoma.